FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

33629611000001106: Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Dec 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2119261000001110 Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2119271000001117 Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Oxycodone hydrochloride 30mg m/r tablet false Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Leveraxo true Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Oxycodone 30mg modified-release tablets false Inferred relationship Existential restriction modifier
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Oxycodone 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) 56 tablet 4 x 14 tablets Has AMP True Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start